Parthenium incanum
Parthenium incanum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Parthenium incanum is a plant species that has gained scientific interest due to its diverse pharmacological potential. Research has specifically identified its various fractions as having significant therapeutic properties. Among its most notable bioactive constituents is Argentatin C, a chemical compound found within the plant. Studies suggest that these components can be utilized for their potent analgesic activities. Consequently, this plant holds promise as a natural intervention for managing conditions such as postsurgical pain.
- Synonyms
- Parthenium Ramosissimum
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Parthenium incanum is a versatile plant known by several distinct names across different linguistic and regional contexts. In many English-speaking areas, it is frequently referred to by its common name, Mariola. The species is also identified in Polish as gwajula meksykańska, highlighting its botanical connections. Moving to East Asian nomenclature, the plant is recognized as 新墨西哥銀膠菊. These diverse names reflect the widespread global presence and cultural recognition of this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Parthenium incanum is a botanical species that is frequently identified by its alternative scientific designation. In many taxonomic databases, this plant is listed under the synonym Parthenium ramosissimum. Understanding these overlapping names is essential for researchers conducting accurate field studies. Such nomenclatural relationships ensure that data remains consistent across various biological studies. Consequently, recognizing both terms allows for a clearer comprehension of the plant's botanical history.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Parthenium incanum is a fascinating specimen that belongs to the vast kingdom Plantae. Within this biological realm, the plant is specifically classified under the class Equisetopsida. It occupies a distinct position within the order Asterales, showcasing its unique evolutionary lineage. Furthermore, this species is a member of the widely recognized family Asteraceae. Ultimately, its taxonomic identity is defined by its placement within the genus Parthenium.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Parthenium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Parthenium incanum exhibits an expansive distribution that spans much of Northern America and various regions within Mexico. This resilient species is widely established throughout Central Mexico and continues to flourish along the Gulf coast. Its presence is equally notable in the Northeast and Northwest sectors of the country, showcasing significant geographic versatility. Furthermore, the plant maintains a strong foothold across the Southwest, anchoring itself in diverse climates. Collectively, these patterns highlight the widespread ecological footprint of the species across the North American landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Parthenium incanum is characterized by its distinct shrub-like growth form. As a self-supporting plant, it maintains its structure independently within its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Parthenium incanum has demonstrated significant analgesic potential through the identification of its bioactive components. Researchers discovered that fractions derived from this medicinal plant contain a cycloartane-type triterpene known as argentatin C. This specific compound works by inhibiting both voltage-gated sodium and T-type voltage-gated calcium channels, which are critical to pain signaling. In animal models, argentatin C successfully reversed mechanical allodynia, providing a promising alternative to traditional opioid treatments. These findings suggest that the plant offers a valuable natural source for developing novel therapies to manage postoperative pain.
Compounds
Parthenium incanum serves as a vital source of natural compounds that may offer new solutions for managing postoperative pain. Researchers studying this Native American medicinal plant successfully isolated a specific cycloartane-type triterpene known as argentatin C. This bioactive molecule demonstrates a unique ability to attenuate pain by inhibiting both voltage-gated sodium and T-type voltage-gated calcium channels. Through various electrophysiological and behavioral studies, argentatin C was shown to reduce neuronal excitability and reverse mechanical allodynia in animal models. These findings highlight the significant potential of argentatin C as a novel therapeutic candidate for treating painful conditions without the risks associated with opioids.
Conditions
Parthenium incanum contains a natural product known as argentatin C that serves to attenuate postoperative pain. This cycloartane-type triterpene works by inhibiting voltage-gated sodium and T-type voltage-gated calcium channels involved in sensory processing. Through its dual effect on these channels, the compound reduces neuronal excitability in both rat and macaque dorsal root ganglion neurons. In practical applications, argentatin C has been shown to reverse mechanical allodynia within a mouse model of postsurgical pain. These findings suggest that the plant's derivatives offer significant potential as a novel, safe analgesic for treating painful surgical conditions.
Preparations
Parthenium incanum is prepared as various fractions to aid in the identification of biologically active compounds. These specific fractions were assessed using depolarization-evoked calcium influx in rat dorsal root ganglion neurons. Through the further separation of these fractions, researchers successfully isolated the cycloartane-type triterpene known as argentatin C. This isolated compound was then evaluated for its ability to block voltage-gated sodium and calcium channels. Ultimately, the study demonstrates how the preparation of these plant fractions can lead to the discovery of potential treatments for postoperative pain.